SUIT-011: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 21: Line 21:
! Pathway control
! Pathway control
! Pathway to Q
! Pathway to Q
! Comment


|-
|-
Line 27: Line 28:
| [[N]]
| [[N]]
| CI
| CI
| ''See'' 2D.


|-
|-
Line 33: Line 36:
| [[N]]
| [[N]]
| CI
| CI
| GM and PM yield practically identical fluxes in human skeletal muscle fibres. However, PM is the superior alternative to GM, since the fractions of the N-pathway is lower and of the S-pathway is higher with GM compared to PM. PM, therefore, yields a more sensitive assay for the diagnosis of injuries in the N-linked (CI-linked) pathway. ''Compare'' [[SUIT targetRP1 NS]] and [[SUIT RP1]].


|-
|-
| 3c
| 3c
| [[GM]](P)c
| [[GM]](c)
| [[N]]
| [[N]]
| CI
| CI
| Cytochrome ''c'' added immediately after the earliest ADP-activation step. Application of the cytochrome ''c'' test early in the protocol ensures comparability of all states in case of any effect of ''c'' ([[Gnaiger 2007 MitoPathways]]).


|-
|-
| 4S
| 3S
| [[GMS]](P)
| [[GMS]](P)
| [[NS]]
| [[NS]]
| CI&II
| CI&II
|


|-
|-
Line 51: Line 57:
| [[NS]]
| [[NS]]
| CI&II
| CI&II
| The additive effect of N+S measured separately compared to the combined NS pathway cannot be evaluated in the same coupling state. With N<sub>''P''</sub>, NS<sub>''P''</sub>, NS<sub>''E''</sub>, and S<sub>''E''</sub>. If  independent information is available on S<sub>''P''</sub> =  S<sub>''E''</sub>, the additivity can be calculated for the OXPHOS state.


|-
|-
Line 57: Line 64:
| [[S]]
| [[S]]
| CII
| CII
| A succinate concentration of >10 mM may be required for saturating S<sub>''E''</sub> capacity.


|-
|-
Line 63: Line 71:
| ROX
| ROX
| ROX  
| ROX  
| ROX may be lower in substrate states earlier in the SUIT protocol. Therefore, this ROX measurement is frequently taken as a methodological control rather than as the basis of ROX correction of mitochondrial respiration (mt).


|}
|}

Revision as of 09:51, 30 August 2016


high-resolution terminology - matching measurements at high-resolution


SUIT-011

Description

SUIT-catg: NS

Abbreviation: NS_1GM 2D 3c 4S 5U 6Rot 7Ama

Reference: MiPNet12.23 FibreRespiration


MitoPedia concepts: SUIT protocol 

Subcatg: N+NS+S
SUIT protocol pattern: diametral
Mark names in DatLab: MiPNet12_23_FibreRespiration
DatLab-Excel template: SUIT_MiPNet12.23_FibreRespiration.xlsx
SUIT states: 1-3GM(LPc) 4-5GMS(PE) 6S 7ROX
Step Respiratory state Pathway control Pathway to Q Comment
1GM GM(L) N CI See 2D.


2D GM(P) N CI GM and PM yield practically identical fluxes in human skeletal muscle fibres. However, PM is the superior alternative to GM, since the fractions of the N-pathway is lower and of the S-pathway is higher with GM compared to PM. PM, therefore, yields a more sensitive assay for the diagnosis of injuries in the N-linked (CI-linked) pathway. Compare SUIT targetRP1 NS and SUIT RP1.
3c GM(c) N CI Cytochrome c added immediately after the earliest ADP-activation step. Application of the cytochrome c test early in the protocol ensures comparability of all states in case of any effect of c (Gnaiger 2007 MitoPathways).
3S GMS(P) NS CI&II
5U GMS(E) NS CI&II The additive effect of N+S measured separately compared to the combined NS pathway cannot be evaluated in the same coupling state. With NP, NSP, NSE, and SE. If independent information is available on SP = SE, the additivity can be calculated for the OXPHOS state.
6Rot S(E) S CII A succinate concentration of >10 mM may be required for saturating SE capacity.
10Ama ROX ROX ROX may be lower in substrate states earlier in the SUIT protocol. Therefore, this ROX measurement is frequently taken as a methodological control rather than as the basis of ROX correction of mitochondrial respiration (mt).
Cookies help us deliver our services. By using our services, you agree to our use of cookies.